Year To Quarter End Statement Of Income

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7547517

Concept 2023-04-01 to
2023-06-30
2023-04-01 to
2023-06-30
2023-04-01 to
2023-06-30
2023-04-01 to
2023-06-30
2023-04-01 to
2023-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
Year to quarter end statement of income
Statement of income
Net sales
605,000,000 JPY
18,150,000,000 JPY
17,545,000,000 JPY
18,150,000,000 JPY
JPY
615,000,000 JPY
17,582,000,000 JPY
18,197,000,000 JPY
JPY
18,197,000,000 JPY
Cost of sales
8,094,000,000 JPY
8,157,000,000 JPY
Gross profit (loss)
10,056,000,000 JPY
10,040,000,000 JPY
Selling, general and administrative expenses
6,762,000,000 JPY
5,983,000,000 JPY
Selling, general and administrative expenses
Salaries
1,417,000,000 JPY
1,407,000,000 JPY
Operating profit (loss)
321,000,000 JPY
3,293,000,000 JPY
2,972,000,000 JPY
3,293,000,000 JPY
JPY
295,000,000 JPY
3,760,000,000 JPY
4,056,000,000 JPY
JPY
4,056,000,000 JPY
Non-operating income
Interest income
2,000,000 JPY
1,000,000 JPY
Dividend income
247,000,000 JPY
229,000,000 JPY
Non-operating income
256,000,000 JPY
281,000,000 JPY
Non-operating expenses
Interest expenses
4,000,000 JPY
4,000,000 JPY
Non-operating expenses
61,000,000 JPY
5,000,000 JPY
Ordinary profit (loss)
3,488,000,000 JPY
4,332,000,000 JPY
Extraordinary income
Extraordinary income
0 JPY
0 JPY
Extraordinary losses
Impairment losses
JPY
304,000,000 JPY
Extraordinary losses
38,000,000 JPY
324,000,000 JPY
Profit (loss) before income taxes
3,451,000,000 JPY
4,008,000,000 JPY
Income taxes
940,000,000 JPY
1,100,000,000 JPY
Profit (loss)
2,510,000,000 JPY
2,907,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.